Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section
Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section
The aforementioned study was designed to evaluate short term ovarian reserve as assessed by
 anti-Mullerian hormone(AMH) levels following bilateral salpingectomy versus tubal ligation,
 as part of cesarean sections performed in women requesting future sterilization. The
 investigators aim to recruit 3 groups of 15 women undergoing elective cesarean section at the
 investigators' institution, 2 of which request sterilization (allocated to tubal ligation or
 bilateral salpingectomy) and one undergoing solely cesarean section. The groups will have
 blood drawn for AMH prior to the procedure and at a post-operation visit 8 weeks following.
 This is preformed in light of validated data offering better sterilization and possible
 diminished future risk of ovarian cancer with salpingectomy. Also, is has been proved to be
 just as safe as tubal ligation. This will be performed as a randomized controlled trial.
Inclusion Criteria:

 -  Women undergoing elective cesrean section at the investigators' institution,
 requesting sterilization, willing to have blood withdrawn for AMH levels prior to
 surgery, willing to participate in 8 weeks post-operation follow up with blood
 withdrawn

 Exclusion Criteria:

 -  Non-elective cesarean section, non willing to have blood withdrawn or participate in
 follow up, prior salpingectomy, prior premature ovarian failure/egg donation